These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10586048)

  • 1. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.
    Davoust N; Nataf S; Reiman R; Holers MV; Campbell IL; Barnum SR
    J Immunol; 1999 Dec; 163(12):6551-6. PubMed ID: 10586048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine complement C4 is not required for experimental autoimmune encephalomyelitis.
    Boos LA; Szalai AJ; Barnum SR
    Glia; 2005 Jan; 49(1):158-60. PubMed ID: 15390104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
    Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
    Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.
    Elhofy A; Wang J; Tani M; Fife BT; Kennedy KJ; Bennett J; Huang D; Ransohoff RM; Karpus WJ
    J Leukoc Biol; 2005 Feb; 77(2):229-37. PubMed ID: 15539456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
    Reiman R; Campos Torres A; Martin BK; Ting JP; Campbell IL; Barnum SR
    Neurosci Lett; 2005 Dec; 390(3):134-8. PubMed ID: 16154690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
    J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
    Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
    J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3a expressed in the central nervous system protects against LPS-induced shock.
    Boos L; Szalai AJ; Barnum SR
    Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice.
    Rancan M; Morganti-Kossmann MC; Barnum SR; Saft S; Schmidt OI; Ertel W; Stahel PF
    J Cereb Blood Flow Metab; 2003 Sep; 23(9):1070-4. PubMed ID: 12973023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna.
    Panitch H; Petursson G; Georgsson G; Palsson PA; Nathanson N
    Lab Invest; 1976 Nov; 35(5):452-60. PubMed ID: 186662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice.
    Jansson L; Olsson T; Höjeberg B; Holmdahl R
    Eur J Immunol; 1991 Mar; 21(3):693-9. PubMed ID: 1707002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.
    Miyamoto K; Miyake S; Mizuno M; Oka N; Kusunoki S; Yamamura T
    Brain; 2006 Aug; 129(Pt 8):1984-92. PubMed ID: 16835249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis.
    Pagenstecher A; Lassmann S; Carson MJ; Kincaid CL; Stalder AK; Campbell IL
    J Immunol; 2000 May; 164(9):4481-92. PubMed ID: 10779748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.